Natriumklorid Baxter (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumklorid Baxter, is an electrolyte presented as an injection solution for intravenous use. It restores sodium and chloride concentrations and expands extracellular fluid volume, supporting patients with fluid loss, electrolyte imbalance, dehydration, or hypovolemia in acute care settings.

GNH USA supplies Natriumklorid Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Natriumklorid Baxter is used in clinical situations that require rapid restoration of fluid and electrolyte balance.

- Fluid replacement: restores intravascular volume in patients with acute fluid loss. - Electrolyte balance: normalizes sodium and chloride levels during electrolyte disturbances. - Dehydration: rehydrates individuals who have lost water and salts due to illness or surgery. - Hypovolemia: expands extracellular fluid volume in cases of low blood volume.

Adverse reactions may occur with any intravenous solution and should be monitored.

Common Side Effects: - Phlebitis at the infusion site. - Local infiltration or swelling. - Mild hypertension. - Transient hypernatremia. - Edema in susceptible patients. - Mild metabolic acidosis due to chloride load.

Serious or Rare Side Effects: - Severe hypernatremia leading to neurologic symptoms. - Hyperchloremic metabolic acidosis. - Anaphylactoid reactions. - Cardiac overload in patients with compromised heart function. - Electrolyte imbalance causing arrhythmias. - Bacterial contamination of the solution.

When using Natriumklorid Baxter, consider the following safety measures.

- Assess fluid status: ensure the patient is not volume overloaded before infusion. - Monitor electrolytes: check serum sodium and chloride levels regularly during therapy. - Cardiac monitoring: observe for signs of hypertension or cardiac strain in at‑risk patients. - Compatibility: verify compatibility with other IV medications before co‑administration. - Infusion rate: adjust the rate according to clinical condition and institutional protocols. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Natriumklorid Baxter may interact with other agents affecting fluid and electrolyte balance.

Major Interactions (Avoid): - Co‑administration with hypertonic saline solutions: risk of severe hypernatremia. - Simultaneous infusion of potassium chloride without monitoring: potential electrolyte imbalance. - Use with nephrotoxic drugs in renal impairment: may exacerbate kidney injury.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase sodium loss and require electrolyte monitoring. - Corticosteroids: can affect fluid retention and electrolyte status. - ACE inhibitors or ARBs: may potentiate hypotensive effects when combined with large volume infusions.